Goodwin advised Miro in its acquisition of Freehand. Miro has acquired the visual collaboration platform, Freehand, from InVision. The deal includes the technology and brand assets, customer...
Miro’s Acquisition of Freehand
Applied Intuition, Inc.’s Acquisition of Embark Technology, Inc.
Wilson Sonsini advised Embark Technology on the transaction, while Goodwin Procter advised Applied Intuition. Applied Intuition, Inc., a tooling and software provider for autonomous vehicle development,...
Latch’s Acquisition of Honest Day’s Work
Goodwin advised Honest Day’s Work on the deal. Latch, Inc. (NASDAQ: LTCH) announced that it has entered into a definitive agreement to acquire Honest Day’s Work...
Accordion’s Acquisition of ABACI
Goodwin Procter advised ABACI on the deal. Accordion, a private equity-focused financial and technology consulting firm, announced that it has acquired ABACI, an Enterprise Resourcing Planning...
Beckett’s Acquisition of Due Dilly
Goodwin Procter advised Due Dilly on the deal. Due Dilly announced its acquisition by Beckett. Due Dilly is an app and marketplace for trading sports card collectibles....
Universal Navigation’s Acquisition of Genie
Goodwin advised Universal Navigation, Inc. on the deal. Universal Navigation, Inc. (Uniswap) announced its acquisition of NFT marketplace aggregator Genie. Uniswap plans to integrate NFTs into its...
Shopify’s Acquisition of Deliverr
Goodwin Procter advised Deliverr, Inc. on the deal, while Paul, Weiss advised Shopify. Deliverr, Inc. announced its agreement to be acquired by Shopify Inc. (NYSE, TSX: SHOP)....
Marvell Technology’s Acquisition of Innovium
Goodwin Procter advised Innovium on the deal. Innovium announced its acquisition by Marvell Technology (NASDAQ: MRVL) in an all-stock transaction, which closed on October 5, 2021. Under...
Synaptics Incorporated’s Acquisition of DSP Group
Goodwin Procter advised Synaptics Incorporated on the deal while Morrison & Foerster represented DSP Group, Inc. Synaptics Incorporated (Nasdaq: SYNA) and DSP Group, Inc. (Nasdaq: DSPG)...
AbbVie’s Acquisition of Mitokinin
Jones Day advised AbbVie Inc on the deal. Mitokinin, Inc., a biotechnology company developing PINK1-targeted therapeutics for the treatment of neurodegenerative diseases, announced that AbbVie, a leading...